News
Stockhead on MSN37m
Neurizon’s lead drug crosses blood-brain barrier, reinforcing ALS treatment potentialNeurizon reports encouraging new rodent preclinical pharmacokinetic data for its lead candidate NUZ-001, showing it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback